Published in J Cancer Res Clin Oncol on May 04, 2010
An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med Genomics (2012) 1.36
Regulation of microRNAs by epigenetics and their interplay involved in cancer. J Exp Clin Cancer Res (2013) 1.14
Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma. J Transl Med (2014) 1.09
miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2. Oncol Lett (2013) 1.03
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC. Leukemia (2012) 0.96
MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1. Int J Mol Med (2015) 0.93
miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression. PLoS One (2015) 0.92
Let-7 microRNAs regenerate peripheral nerve regeneration by targeting nerve growth factor. Mol Ther (2014) 0.92
Depletion of intermediate filament protein Nestin, a target of microRNA-940, suppresses tumorigenesis by inducing spontaneous DNA damage accumulation in human nasopharyngeal carcinoma. Cell Death Dis (2014) 0.90
Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7. Exp Ther Med (2012) 0.85
Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma. J Transl Med (2015) 0.83
let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis. J Transl Med (2014) 0.83
The role of microRNAs in nasopharyngeal carcinoma. Tumour Biol (2014) 0.82
MicroRNAs Regulate Key Effector Pathways of Senescence. J Aging Res (2011) 0.82
Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers. Chin J Cancer (2014) 0.81
Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer. World J Surg Oncol (2011) 0.81
Downregulation of microRNA-21 enhances radiosensitivity in nasopharyngeal carcinoma. Exp Ther Med (2015) 0.78
p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA. Oncogene (2016) 0.77
miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation. Exp Ther Med (2016) 0.76
Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression. Onco Targets Ther (2016) 0.75
Functions of microRNA-143 in the apoptosis, invasion and migration of nasopharyngeal carcinoma. Exp Ther Med (2016) 0.75
Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients. J Cell Mol Med (2016) 0.75
Regulation of viral oncogenesis by microRNAs. Mol Cell Oncol (2014) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A (2006) 10.11
Transcription and processing of human microRNA precursors. Mol Cell (2004) 8.98
Nasopharyngeal carcinoma. Lancet (2005) 7.16
The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 6.61
RNAi: nature abhors a double-strand. Curr Opin Genet Dev (2002) 5.74
MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res (2007) 5.25
let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull (2006) 4.42
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A (2008) 4.06
The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer (2010) 3.95
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer (2009) 2.57
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol (2009) 2.57
Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res (2007) 2.45
Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci U S A (1989) 2.01
Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer (1980) 1.94
Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin Cancer Res (2004) 1.23
hTERT mRNA expression correlates with telomerase activity in human breast cancer. Eur J Surg Oncol (2003) 1.13
Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. Ann N Y Acad Sci (2005) 1.11
Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma. Int J Cancer (2008) 1.00
The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol (1994) 0.91
Azacitidine and the beginnings of therapeutic epigenetic modulation. Expert Opin Pharmacother (2008) 0.87
Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells. J Laryngol Otol (2006) 0.80
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res (2008) 5.46
Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation (2003) 1.61
Reconstruction of circumferential pharyngeal defects after tumour resection: reference or preference. J Plast Reconstr Aesthet Surg (2011) 1.61
Extracranial head and neck Schwannomas: a study of the nerve of origin. Eur Arch Otorhinolaryngol (2011) 1.54
Trans-oral brush biopsies and quantitative PCR for EBV DNA detection and screening of nasopharyngeal carcinoma. Otolaryngol Head Neck Surg (2014) 1.50
Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck (2009) 1.49
MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis (2012) 1.47
Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem (2010) 1.42
Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis (2013) 1.34
Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Oncogene (2003) 1.29
Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. Cancer Sci (2004) 1.23
Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin Cancer Res (2004) 1.23
Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck (2003) 1.19
Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer (2004) 1.18
Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells. Carcinogenesis (2009) 1.18
Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment. Int J Cancer (2014) 1.12
Bear bile: dilemma of traditional medicinal use and animal protection. J Ethnobiol Ethnomed (2009) 1.12
Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod Pathol (2004) 1.09
Authentication of nasopharyngeal carcinoma tumor lines. Int J Cancer (2008) 1.08
Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer (2002) 1.06
Arabidopsis thaliana acyl-CoA-binding protein ACBP2 interacts with heavy-metal-binding farnesylated protein AtFP6. New Phytol (2008) 1.06
Cytogenetic aberrations in immortalization of esophageal epithelial cells. Cancer Genet Cytogenet (2006) 1.06
Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient. Int J Cancer (2003) 1.06
Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer. AJR Am J Roentgenol (2004) 1.05
Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J Mol Diagn (2004) 1.05
IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer. J Cell Physiol (2015) 1.04
Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma. J Pathol (2011) 1.04
STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Int J Cancer (2009) 1.02
Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma. Gynecol Oncol (2004) 1.01
Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma. J Pathol (2013) 1.00
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma. PLoS One (2012) 0.99
Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth. Oncogene (2002) 0.99
Operative outcomes of adult-to-adult right lobe live donor liver transplantation: a comparative study with cadaveric whole-graft liver transplantation in a single center. Ann Surg (2006) 0.99
Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. Int J Cancer (2004) 0.99
Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma. Anticancer Res (2012) 0.99
Current management strategy of hypopharyngeal carcinoma. Auris Nasus Larynx (2012) 0.98
Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). Carcinogenesis (2003) 0.97
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines. Invest New Drugs (2009) 0.97
Emissive terbium probe for multiphoton in vitro cell imaging. J Am Chem Soc (2008) 0.95
Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma. Clin Cancer Res (2003) 0.95
Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma. Cancer (2006) 0.95
Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres. Cancer Lett (2013) 0.93
High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients. Clin Cancer Res (2002) 0.93
MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma. Mol Cancer (2013) 0.93
Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer (2004) 0.93
Early resection and reconstruction of head and neck masses in infants with upper airway obstruction. Int J Pediatr Otorhinolaryngol (2010) 0.93
An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation. Biochem Pharmacol (2010) 0.92
Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma. J Pathol (2013) 0.92
Superiority of bilateral cochlear implantation over unilateral cochlear implantation in tone discrimination in chinese patients. Am J Otolaryngol (2003) 0.91
Mucosal melanoma of the head and neck: 32-year experience in a tertiary referral hospital. Laryngoscope (2012) 0.91
Thyroid dysfunction in laryngectomees-10 years after treatment. Head Neck (2008) 0.90
Mature miR-184 and squamous cell carcinoma of the tongue. ScientificWorldJournal (2009) 0.89
Molecular changes during arsenic-induced cell transformation. J Cell Physiol (2011) 0.88
Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells. Invest New Drugs (2010) 0.87
A prospective controlled double-blind trial of great auricular nerve preservation at parotidectomy. Am J Surg (2003) 0.87
Cytokeratin 8 silencing in human nasopharyngeal carcinoma cells leads to cisplatin sensitization. Cancer Lett (2008) 0.86
miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis. Mol Cancer (2014) 0.86
Management of pseudoaneurysms of the internal carotid artery in postirradiated nasopharyngeal carcinoma patients. Laryngoscope (2014) 0.86
Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma. J Pathol (2010) 0.86
The changing role of pectoralis major flap in head and neck reconstruction. Eur Arch Otorhinolaryngol (2010) 0.86
STAT3 as a therapeutic target for Epstein-Barr virus (EBV): associated nasopharyngeal carcinoma. Cancer Lett (2012) 0.86
Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma. PLoS One (2012) 0.86
Transoral robotic resection of recurrent nasopharyngeal carcinoma. Laryngoscope (2010) 0.85
Detection of hypermethylated RIZ1 gene in primary tumor, mouth, and throat rinsing fluid, nasopharyngeal swab, and peripheral blood of nasopharyngeal carcinoma patient. Clin Cancer Res (2003) 0.85
Basal cell carcinoma of the head and neck region in ethnic chinese. Int J Surg Oncol (2011) 0.85
Methylation status of Reprimo in head and neck carcinomas. Int J Cancer (2005) 0.85
Effect of previous radiotherapy on cervical lymph node fine-needle aspiration cytology diagnostic accuracy in head and neck cancers. Laryngoscope (2012) 0.84
Localization and variable expression of G alpha(i2) in human endometrium and Fallopian tubes. Hum Reprod (2007) 0.84
Epigenetic dysregulation in laryngeal squamous cell carcinoma. J Oncol (2012) 0.83
Efficacy of salvage neck dissection for isolated nodal recurrences in early carcinoma of oral tongue with watchful waiting management of initial N0 neck. Head Neck (2010) 0.82
Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation. Invest New Drugs (2009) 0.82
Expression of Epstein-Barr virus-encoded LMP1 and hTERT extends the life span and immortalizes primary cultures of nasopharyngeal epithelial cells. J Med Virol (2010) 0.82
The multistage process of carcinogenesis in human esophageal epithelial cells induced by human papillomavirus. Oncol Rep (2004) 0.82
Hypoxia in head and neck squamous cell carcinoma. ISRN Otolaryngol (2012) 0.82
Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. Exp Ther Med (2010) 0.82
Prediction of surgical outcome using plasma Epstein-Barr virus dna and (18)F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma. Head Neck (2011) 0.81
Postradiation sarcoma after radiotherapy for nasopharyngeal carcinoma. Laryngoscope (2012) 0.81
Quality of life in patients with laryngopharyngeal reflux. Digestion (2008) 0.81
Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening. Tumour Biol (2002) 0.81
Hormonal regulation of Galphai2 and mPRalpha in immortalized human oviductal cell line OE-E6/E7. Mol Hum Reprod (2007) 0.81
Anti-cancer effects of curcumin on head and neck cancers. Anticancer Agents Med Chem (2012) 0.81
Curcumin alters the migratory phenotype of nasopharyngeal carcinoma cells through up-regulation of E-cadherin. Anticancer Res (2010) 0.81